Karuna Therapeutics, Inc.

Bank of New York Mellon Corp

Report date

12/31/2023

Quarter

2023 Q4

Filed

1/29/2024

Shares

201,828

Value ($000)

63,881

Weight

0.0%

2019 Q4 - 2023 Q4 (17 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q4	1/29/2024	63,881	0.0%	201,828	12/31/2023
2023 Q3	10/24/2023	35,520	0.0%	210,065	9/30/2023
2023 Q2	8/3/2023	43,934	0.0%	202,601	6/30/2023
2023 Q1	5/9/2023	39,943	0.0%	219,902	3/31/2023
2022 Q4	2/14/2023	42,522	0.0%	216,398	12/31/2022
2022 Q3	11/14/2022	49,215	0.0%	218,802	9/30/2022
2022 Q2	8/15/2022	33,442	0.0%	264,339	6/30/2022
2022 Q1	5/11/2022	26,839	0.0%	211,678	3/31/2022
2021 Q4	2/11/2022	11,917	0.0%	90,969	12/31/2021
2021 Q3	11/18/2021	10,941	0.0%	89,439	9/30/2021
2021 Q2	8/11/2021	9,269	0.0%	81,317	6/30/2021
2021 Q1	5/13/2021	7,343	0.0%	61,078	3/31/2021
2020 Q4	2/9/2021	6,590	0.0%	64,869	12/31/2020
2020 Q3	11/12/2020	5,150	0.0%	66,607	9/30/2020
2020 Q2	8/12/2020	8,003	0.0%	71,805	6/30/2020
2020 Q1	5/6/2020	3,983	0.0%	55,308	3/31/2020
2019 Q4	2/14/2020	2,998	0.0%	39,800	12/31/2019